New York, NYNCT06812494Now EnrollingIRB Ready

HIV Prevention Clinical Trial in New York, NY

Access cutting-edge hiv prevention treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by National Institute of Allergy and Infectious Diseases (NIAID)

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions...

Expert Care in New York

Access hiv prevention specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hiv prevention treatment provided free

Apply for This New York Location

Check if you qualify for this hiv prevention clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This HIV Prevention Study in New York

HVTN 206/HPTN 114 is a randomized, double blind, controlled, phase 2 clinical trial to evaluate the safety, tolerability, pharmacokinetics, and neutralization of VRC07-523LS, PGT121.414.LS, and PGDM1400LS broadly neutralizing monoclonal antibodies given intravenously in adult participants without HIV. The hypothesis of the study is that the combination of VRC07-523LS and PGT121.414.LS and PGDM1400LS antibodies when administered via the intravenous (IV) route will be safe and tolerable in adult

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Who Can Participate

Inclusion Criteria

Participants need to be between 18 and 65 years old.
Participants must have access to a participating clinical research site and be willing to follow the study schedule.
Participants should understand the study details and be willing to give informed consent.
Participants must agree not to join any other clinical trials until they finish this study.
Participants must be willing to receive HIV test results.
Participants should be open to discussing HIV prevention.
Clinic staff should assess participants as having a low risk of getting HIV, and participants must commit to avoiding high-risk behaviors during the study.
Hemoglobin: Participant meets minimum levels depending on gender and hormone therapy status.
White Blood Cells (WBC): Should be within the normal range or approved by a site clinician.
Platelets: At least 100,000 cells/mm³.
Alanine aminotransferase (ALT): Less than 5 times the upper normal limit.
Creatinine: Less than 1.8 times t

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT06812494) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

HIV Prevention Treatment Options in New York, NY

If you're searching for hiv prevention treatment options in New York, NY, this clinical trial (NCT06812494) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiv prevention specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hiv prevention clinical trials near you to find additional studies recruiting in your area.

More HIV AIDS Trials in New York, NY

See all hiv aids clinical trials recruiting in New York — not just this study.

Browse HIV AIDS Trials in New York →

Browse More Trials by Condition

HIV AIDS TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY